Cargando…
Clinical efficacy of CT-guided (125)I brachytherapy in patients with local residual or recurrent hepatocellular carcinoma after thermal ablation
OBJECTIVES: Treatment methods of local residual or recurrent hepatocellular carcinoma (HCC) after thermal ablation are limited. Therefore, our study aimed to explore the efficacy and prognostic factors of (125)I brachytherapy for local residual or recurrent lesion after thermal ablation. METHODS: A...
Autores principales: | Zhu, Wenliang, Zhong, Zhihui, Yan, Huzheng, Guo, Huanqing, Xiao, Meigui, He, Xu, Gao, Fei, Zhang, Fujun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723008/ https://www.ncbi.nlm.nih.gov/pubmed/36471084 http://dx.doi.org/10.1186/s13244-022-01327-z |
Ejemplares similares
-
CT-guided (125)I brachytherapy for locally recurrent nasopharyngeal carcinoma
por: Yan, Huzheng, et al.
Publicado: (2017) -
CT-guided (125)I brachytherapy in the treatment of distant metastases in the oral cavity and maxillofacial region
por: Yan, Huzheng, et al.
Publicado: (2016) -
Clinical efficacy and prognostic factors of CT-guided (125)I brachytherapy for the palliative treatment of retroperitoneal metastatic lymph nodes
por: Yan, Huzheng, et al.
Publicado: (2020) -
CT-guided (125)I brachytherapy for recurrent ovarian cancer
por: Liu, Ping, et al.
Publicado: (2017) -
(125)I seed brachytherapy versus external beam radiation therapy for the palliation of painful bone metastases of lung cancer after one cycle of chemotherapy progression
por: Xiang, Zhanwang, et al.
Publicado: (2018)